In this research, next–generation sequencing (NGS) was conducted on paraffin samples of individuals with DLBCL who had undergone R–CHOP or R–CHOP–like treatments, and characteristic analysis was conducted in terms of TP53 gene alterations to compare with clinical characteristics. Here, DDIT3 is linked to diffuse large B-cell lymphoma.